Ajax Therapeutics
Latest round
- Series C
Last raised
- Apr 2024
Total raised
- $95M
Investors
- 9
About Ajax Therapeutics
Based in New York, US, and founded in 2019 by co-founders Ross Levine MD, Olli Silvennoinen, and Martin Vogelbaum (CEO), Ajax Therapeutics, Inc. operates as a provider of next-generation JAK2 inhibitors and targeted therapies for hematologic cancers to pharmaceutical companies and oncology research institutions. In April 2024, Ajax Therapeutics, Inc., and Inning One Ventures. The company provides a wide range of therapeutic solutions, such as selective Type II JAK2 inhibitors for hematologic cancers, including myeloproliferative neoplasms (MPNs).
Who invested in Ajax Therapeutics
9 investors across 1 round
See all investors in Ajax Therapeutics
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Apr 26, 2024
Amount
$95M
Investors
Questions about Ajax Therapeutics
Who invested in Ajax Therapeutics?
Ajax Therapeutics has 9 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Ajax Therapeutics raised?
Ajax Therapeutics has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Ajax Therapeutics last raise money?
Ajax Therapeutics's most recent round on record is a Series C, in Apr 2024.
What does Ajax Therapeutics do?
Based in New York, US, and founded in 2019 by co-founders Ross Levine MD, Olli Silvennoinen, and Martin Vogelbaum (CEO), Ajax Therapeutics, Inc.
Where is Ajax Therapeutics headquartered?
Ajax Therapeutics is headquartered in New York, US.
Which VCs invest in companies like Ajax Therapeutics?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Ajax Therapeutics's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Ajax Therapeutics? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.